Strain differences in the effects of adrenalectomy on the midbrain dopamine system: Implication for behavioral sensitization to cocaine

Neuroscience

Volumn 153, Issue 3, 2008, Pages 594-604

  de Jong, I E M ^a,b   Steenbergen, P J ^a   de Kloet, E R ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b H LUNDBECK A S   (Denmark)

Author keywords

C57BL 6; DBA 2; genotype; glucocorticoids; HPA axis; locomotion

Indexed keywords

COCAINE; DOPAMINE TRANSPORTER; MESSENGER RNA; TYROSINE 3 MONOOXYGENASE;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; DRUG SENSITIZATION; EXPERIMENTAL STUDY; GENOTYPE; MALE; MESENCEPHALON; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 43049131402     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.03.004     Document Type: Article

References (71)

1. Ackerman JM, White FJ (1990) A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment. Neurosci Lett 117:181–187.
2. Badiani A, Cabib S, Puglisi-Allegra S (1992) Chronic stress induces strain-dependent sensitization to the behavioral effects of amphetamine in the mouse. Pharmacol Biochem Behav 43:53–60.
3. Bahi A, Boyer F, Bussard G, Dreyer JL (2005) Silencing dopamine D3-receptors in the nucleus accumbens shell in vivo induces changes in cocaine-induced hyperlocomotion. Eur J Neurosci 21: 3415–3426.
4. Barrot M, Marinelli M, Abrous DN, Rouge-Pont F, Le Moal M, Piazza PV (2000) The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens is hormone-dependent. Eur J Neurosci 12:973–979.
5. Beitner-Johnson D, Nestler EJ (1991) Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J Neurochem 57:344–347.
6. Berman SM, Noble EP (1997) The D2 dopamine receptor (DRD2) gene and family stress; interactive effects on cognitive functions in children. Behav Genet 27:33–43.
7. Biron D, Dauphin C, Di Paolo T (1992) Effects of adrenalectomy and glucocorticoids on rat brain dopamine receptors. Neuroendocrinology 55:468–476.
8. Cabib S (1993) Strain-dependent behavioural sensitization to amphetamine: role of environmental influences. Behav Pharmacol 4:367–374.
9. Cabib S, Algeri S, Perego C, Puglisi-Allegra S (1990) Behavioral and biochemical changes monitored in two inbred strains of mice during exploration of an unfamiliar environment. Physiol Behav 47:749–753.
10. Cabib S, Bonaventura N (1997) Parallel strain-dependent susceptibility to environmentally-induced stereotypies and stress-induced behavioral sensitization in mice. Physiol Behav 61:499–506.
11. Cabib S, Giardino L, Calza L, Zanni M, Mele A, Puglisi-Allegra S (1998) Stress promotes major changes in dopamine receptor densities within the mesoaccumbens and nigrostriatal systems. Neuroscience 84:193–200.
12. Cabib S, Kempf E, Schleef C, Oliverio A, Puglisi-Allegra S (1988) Effects of immobilization stress on dopamine and its metabolites in different brain areas of the mouse: role of genotype and stress duration. Brain Res 441:153–160.
13. Cabib S, Orsini C, Le Moal M, Piazza PV (2000) Abolition and reversal of strain differences in behavioral responses to drugs of abuse after a brief experience. Science 289:463–465.
14. Cadoni C, Solinas M, Di Chiara G (2000) Psychostimulant sensitization: differential changes in accumbal shell and core dopamine. Eur J Pharmacol 388:69–76.
15. Cador M, Dulluc J, Mormede P (1993) Modulation of the locomotor response to amphetamine by corticosterone. Neuroscience 56: 981–988.
16. Capper-Loup C, Canales JJ, Kadaba N, Graybiel AM (2002) Concurrent activation of dopamine D1 and D2 receptors is required to evoke neural and behavioral phenotypes of cocaine sensitization. J Neurosci 22:6218–6227.
17. Conversi D, Orsini C, Cabib S (2004) Distinct patterns of Fos expression induced by systemic amphetamine in the striatal complex of C57BL/6JICo and DBA/2JICo inbred strains of mice. Brain Res 1025:59–66.
18. Czyrak A, Wedzony K, Michalska B, Fijal K, Dziedzicka-Wasylewska M, Mackowiak M (1997) The corticosterone synthesis inhibitor metyrapone decreases dopamine D1 receptors in the rat brain. Neuroscience 79:489–495.
19. de Jong IEM, Oitzl MS, de Kloet ER (2007) Adrenalectomy prevents behavioural sensitisation of mice to cocaine in a genotype-dependent manner. Behav Brain Res 177:329–339.
20. Deroche V, Piazza PV, Casolini P, Le Moal M, Simon H (1993) Sensitization to the psychomotor effects of amphetamine and morphine induced by food restriction depends on corticosterone secretion. Brain Res 611:352–356.
21. D’Este L, Casini A, Puglisi-Allegra S, Cabib S, Renda TG (2007) Comparative immunohistochemical study of the dopaminergic systems in two inbred mouse strains (C57BL/6J and DBA/2J). J Chem Neuroanat 33:67–74.
22. Ellenbroek BA, van der Kam EL, van der Elst MCJ, Cools AR (2005) Individual differences in drug dependence in rats: The role of genetic factors and life events. Eur J Pharmacol 526:251–258.
23. Erblich J, Lerman C, Self DW, Diaz GA, Bovbjerg DH (2004) Stressinduced cigarette craving: effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms. Pharmacogenomics J 4:102–109.
24. Erwin VG, Womer DE, Campbell AD, Jones BC (1993) Pharmacogenetics of cocaine: II. Mesocorticolimbic and striatal dopamine and cocaine receptors in C57BL and DBA mice. Pharmacogenetics 3:189–196.
25. Everitt BJ, Wolf ME (2002) Psychomotor stimulant addiction: A neural systems perspective. J Neurosci 22:3312–3320.
26. Filip M, Siwanowicz J (2001) Implication of the nucleus accumbens shell, but not core, in the acute and sensitizing effects of cocaine in rats. Pol J Pharmacol 53:459–466.
27. Fink JS, Reis DJ (1981) Genetic variations in midbrain dopamine cell number: Parallel with differences in responses to dopaminergic agonists and in naturalistic behaviors mediated by central dopaminergic systems. Brain Res 222:335–349.
28. Franklin KB, Paxinos G (1997) The mouse brain in stereotaxic coordinates. San Diego: Academic Press Inc.
29. Goeders NE (2002) Stress and cocaine addiction. J Pharmacol Exp Ther 301:785–789.
30. Hummel KP (1958) Accessory adrenal cortical nodules in the mouse. Anat Rec 132:281–295.
31. Ishihara T, Akiyama K, Kashihara K (1998) Enhanced AP-1 binding in brain induced by D1 and D2 agonists in methamphetamine-sensitized rats. Neuroreport 9:3913–3917.
32. Jones BC, Sarrieau A, Reed CL, Azar MR, Mormede P (1998) Contribution of sex and genetics to neuroendocrine adaptation to stress in mice. Psychoneuroendocrinology 23:505–517.
33. Kabbaj M, Isgor C (2007) Effects of chronic environmental and social stimuli during adolescence on mesolimbic dopaminergic circuitry markers. Neurosci Lett 422:7–12.
34. Kalivas PW (2004) Glutamate systems in cocaine addiction. Curr Opin Pharmacol 4:23–29.
35. Kumer SC, Vrana KE (1996) Intricate regulation of tyrosine hydroxylase activity and gene expression. J Neurochem 67:443–462.
36. Li Y, Acerbo MJ, Robinson TE (2004) The induction of behavioural sensitization is associated with cocaine-induced structural plasticity in the core (but not shell) of the nucleus accumbens. Eur J Neurosci 20:1647–1654.
37. Lu W, Wolf ME (1997) Expression of dopamine transporter and vesicular monoamine transporter 2 mRNAs in rat midbrain after repeated amphetamine administration. Brain Res Mol Brain Res 49:137–148.
38. Marinelli M, Le Moal M, Piazza PV (1996) Acute pharmacological blockade of corticosterone secretion reverses food restriction-induced sensitization of the locomotor response to cocaine. Brain Res 724:251–255.
39. Marinelli M, Piazza PV (2002) Interaction between glucocorticoid hormones, stress and psychostimulant drugs. Eur J Neurosci 16: 387–394.
40. Marinelli M, Rouge-Pont F, Deroche V, Barrot M, Jesus-Oliveira C, Le Moal M, Piazza PV (1997) Glucocorticoids and behavioral effects of psychostimulants. I: locomotor response to cocaine depends on basal levels of glucocorticoids. J Pharmacol Exp Ther 281:1392–1400.
41. Meliska CJ, Bartke A, McGlacken G, Jensen RA (1995) Ethanol, nicotine, amphetamine, and aspartame consumption and preferences in C57BL/6 and DBA/2 mice. Pharmacol Biochem Behav 50:619–626.
42. Ng GY, O’Dowd BF, George SR (1994) Genotypic differences in brain dopamine receptor function in the DBA/2J and C57BL/6J inbred mouse strains. Eur J Pharmacol 269:349–364.
43. Orsini C, Bonito-Oliva A, Conversi D, Cabib S (2005) Susceptibility to conditioned place preference induced by addictive drugs in mice of the C57BL/6 and DBA/2 inbred strains. Psychopharmacology (Berl) 181:327–336.
44. Paulson PE, Camp DM, Robinson TE (1991) Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology (Berl) 103: 480–492.
45. Piazza PV, Barrot M, Rouge-Pont F, Marinelli M, Maccari S, Abrous DN, Simon H, Le Moal M (1996) Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission. Proc Natl Acad Sci U S A 93:15445–15450.
46. Piazza PV, Deminiere JM, Le Moal M, Simon H (1990) Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res 514:22–26.
47. Piazza PV, Le Moal ML (1996) Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu Rev Pharmacol Toxicol 36:359–378.
48. Pierce RC, Kalivas PW (1995) Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine. J Pharmacol Exp Ther 275:1019–1029.
49. Pierce RC, Kalivas PW (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 25:192–216.
50. Puglisi-Allegra S, Cabib S (1997) Psychopharmacology of dopamine: the contribution of comparative studies in inbred strains of mice. Prog Neurobiol 51:637–661.
51. Richtand NM, Woods SC, Berger SP, Strakowski SM (2001) D3 dopamine receptor, behavioral sensitization, and psychosis. Neurosci Biobehav Rev 25:427–443.
52. Rouge-Pont F, Deroche V, Moal ML, Piazza PV (1998) Individual differences in stress-induced dopamine release in the nucleus accumbens are influenced by corticosterone. Eur J Neurosci 10: 3903–3907.
53. Seale TW, Carney JM (1991) Genetic determinants of susceptibility to the rewarding and other behavioral actions of cocaine. J Addict Dis 10:141–162.
54. Shanks N, Griffiths J, Zalcman S, Zacharko RM, Anisman H (1990) Mouse strain differences in plasma corticosterone following uncontrollable footshock. Pharmacol Biochem Behav 36:515–519.
55. Shilling PD, Kelsoe JR, Segal DS (1997) Dopamine transporter mRNA is up-regulated in the substantia nigra and the ventral tegmental area of amphetamine-sensitized rats. Neurosci Lett 236:131–134.
56. Sorg BA, Chen SY, Kalivas PW (1993) Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine. J Pharmacol Exp Ther 266:424–430.
57. Sorg BA, Kalivas PW (1991) Effects of cocaine and footshock stress on extracellular dopamine levels in the ventral striatum. Brain Res 559:29–36.
58. Ujike H, Akiyama K, Otsuki S (1990) D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine. Psychopharmacology (Berl) 102:459–464.
59. Vanderschuren LJ, Schmidt ED, De Vries TJ, Van Moorsel CA, Tilders FJ, Schoffelmeer AN (1999a) A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats. J Neurosci 19:9579–9586.
60. Vanderschuren LJ, Schoffelmeer AN, Mulder AH, De Vries TJ (1999b) Dopaminergic mechanisms mediating the long-term expression of locomotor sensitization following pre-exposure to morphine or amphetamine. Psychopharmacology (Berl) 143:244–253.
61. Vanderschuren LJ, Schoffelmeer AN, Van Leeuwen SD, Hof L, Jonker AJ, Voorn P (2002) Compartment-specific changes in striatal neuronal activity during expression of amphetamine sensitization are the result of drug hypersensitivity. Eur J Neurosci 16:2462–2468.
62. Van der Veen R, Piazza PV, Deroche-Gamonent V (2007) Gene-environment interactions in vulnerability to cocaine intravenous selfadministration: a brief social experience affects intake in DBA/2J but not in C57BL/6J mice. Psychopharmacology 193:179–186.
63. Ventura R, Alcaro A, Cabib S, Conversi D, Mandolesi L, Puglisi-Allegra S (2004a) Dopamine in the medial prefrontal cortex controls genotype- dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion. Neuropsychopharmacology 29: 72–80.
64. Ventura R, Alcaro A, Mandolesi L, Puglisi-Allegra S (2004b) In vivo evidence that genetic background controls impulse-dependent dopamine release induced by amphetamine in the nucleus accumbens. J Neurochem 89:494–502.
65. Ventura R, Cabib S, Puglisi-Allegra S (2001) Opposite genotypedependent mesocorticolimbic dopamine response to stress. Neuroscience 104:627–631
66. Vrana SL, Vrana KE, Koves TR, Smith JE, Dworkin SI (1993) Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels. J Neurochem 61:2262–2268.
67. Wolf ME, White FJ, Nassar R, Brooderson RJ, Khansa MR (1993) Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J Pharmacol Exp Ther 264:249–255.
68. Yamada S, Yokoo H, Nishi S (1991) Changes in sensitivity of dopamine autoreceptors in rat striatum after subchronic treatment with methamphetamine. Eur J Pharmacol 205:43–47.
69. Yi SJ, Johnson KM (1990) Chronic cocaine treatment impairs the regulation of synaptosomal 3H-DA release by D2 autoreceptors. Pharmacol Biochem Behav 36:457–461.
70. Zaborszky L, Vadasz C (2001) The midbrain dopaminergic system: anatomy and genetic variation in dopamine neuron number of inbred mouse strains. Behav Genet 31:47–59.
71. Zocchi A, Orsini C, Cabib S, Puglisi-Allegra S (1998) Parallel straindependent effect of amphetamine on locomotor activity and dopamine release in the nucleus accumbens: an in vivo study in mice. Neuroscience 82:521–528.